On August 12, the U.S. Food and Drug Administration approved GlaxoSmithKline Plc's drug Tivicay to treat the most common strain of HIV.
http://www.edgefireisland.com/index.php?ch=health_fitness&sc=&sc2=features&sc3=&id=148492
http://www.edgefireisland.com/index.php?ch=health_fitness&sc=&sc2=features&sc3=&id=148492
No comments:
Post a Comment